Dutasteride benign prostatic hyperplasia (BPH) finasteride meta-analysis

Botulinum toxin benign prostatic hyperplasia Meta-analysis

Benign prostatic hyperplasia Enucleation Laser Two-lobe en-bloc

Humans Male Network Meta-Analysis *Prostatic Hyperplasia/surgery Quality of Life Randomized Controlled Trials as Topic *Transurethral Resection of Prostate Treatment Outcome *benign prostatic hyperplasia *network meta-analysis *prostate volume *surgical treatment conflicts of interest with respect to the research authorship and/or publication of this article.

Bph Srd5a2 polymorphism risk susceptibility

*Alleles Ethnicity/genetics *Genetic Association Studies *Genetic Predisposition to Disease Genotype Humans Male Odds Ratio *Polymorphism Single Nucleotide Prostate-Specific Antigen/*genetics Prostatic Hyperplasia/*genetics Publication Bias Risk Factors Bph Psa meta-analysis polymorphism

Benign prostatic hyperplasia surgical treatments meta-analysis

Monodrug Therapies Benign Prostatic Hyperplasia Lower Urinary Tract Symptoms Meta-analysis

Plasmakinetic resection technology benign prostatic hyperplasia meta-analysis

Case-Control Studies Genetic Predisposition to Disease Humans Male Odds Ratio *Polymorphism Genetic Polymorphism Restriction Fragment Length Prostatic Hyperplasia/*genetics Publication Bias Receptors Calcitriol/*genetics Risk

Humans Male *Polymorphism Genetic Prostatic Hyperplasia/*genetics Prostatic Neoplasms/*genetics Receptors Androgen/*genetics *Trinucleotide Repeats

Humans Laser Therapy Length of Stay Male Postoperative Complications Prostatic Hyperplasia Quality of Life Randomized Controlled Trials as Topic Time Factors *Transurethral Resection of Prostate Treatment Outcome Urinary Catheterization